Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Spirax-Sarco Broker Ratings



Broker Ratings for Spirax-Sarco (SPX)


Share Price: 5,440.00Bid: 5,435.00Ask: 5,440.00Change: 0.00 (0.00%)No Movement on Spirax-sarco
Spread: 5.00Spread as %: 0.09%Open: 5,480.00High: 5,530.00Low: 5,420.00Yesterday’s Close: 5,440.00


Broker Recommendations for Spirax-Sarco (SPX)
DateBrokerRatingOld TargetNew TargetChange
03-Dec-17JP Morgan CazenoveNeutral5,800.005,700.00Reiteration
28-Nov-17JefferiesHold5,945.006,010.00Reiteration
12-Oct-17DeutscheBuy-6,530.00Reiteration
09-Aug-17Investec Securitiesnot rated--under review
18-Jul-17Numis SecuritiesAdd-6,000.00Reiteration
02-Jun-17JP Morgan CazenoveNeutral5,000.005,300.00Downgrade
01-Jun-17JefferiesHold5,225.005,905.00Reiteration
01-Jun-17DeutscheBuy-5,785.00Reiteration
09-May-17Numis SecuritiesHold-5,250.00Downgrade
03-May-17DeutscheBuy-5,785.00Reiteration
11-Apr-17JP Morgan CazenoveOverweight4,800.005,000.00Reiteration
06-Apr-17HSBCHold4,300.004,700.00Reiteration
03-Apr-17Numis SecuritiesAdd-5,250.00Reiteration
09-Mar-17Numis SecuritiesHold-4,825.00Downgrade
03-Feb-17DeutscheBuy4,970.004,970.00Reiteration


Registered members see more Spirax-Sarco broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.